Take a guy we’ll call David. Trained six days a week, ate over 200 grams of protein daily, and still bought BCAAs every month because his coach told him they were essential. Four years of this. Roughly $40-60 a month on a BCAA supplement mixed into his intra-workout drink, sipped through his training sessions. He was getting results — good results, actually — but he’d been getting those results since before he started the BCAAs, and they continued at the same rate afterward. No way to attribute anything specifically to the supplement. When he did the math, he’d spent over $2,000 on BCAAs over four years with no measurable return that couldn’t already be explained by his training and diet improvements over the same period.
BCAAs — branched-chain amino acids, specifically leucine, isoleucine, and valine — are among the most widely sold supplements in the fitness market. Also among the most scientifically overhyped for the majority of people taking them. The research case for BCAAs in adequately-fed, protein-sufficient athletes is surprisingly weak. Understanding why requires understanding what BCAAs actually do, and what already makes them unnecessary for most users.
What BCAAs Actually Are
Branched-chain amino acids are three of the nine essential amino acids: leucine, isoleucine, and valine. Named for their branched carbon structure. Classified as essential because the human body can’t synthesize them from other compounds — they must come from the diet. Present in all complete protein sources: meat, fish, eggs, dairy (whey protein is particularly BCAA-rich), and soy protein.
The theoretical case for BCAA supplementation in athletes: during and after exercise, BCAA oxidation increases. Free-form BCAAs can be rapidly absorbed and potentially protect against net muscle protein breakdown during catabolic exercise states. The leucine in BCAAs can trigger MPS independently of a full meal. In fasted states or protein-deficient diets, this supplemental leucine signal might meaningfully stimulate anabolic processes that would otherwise be limited.
The practical problem: these mechanisms primarily apply to specific conditions — fasting, protein deficiency, extreme exercise states — that don’t describe most people taking BCAAs. Once total protein intake is adequate, and leucine from dietary protein reaches the threshold needed to stimulate MPS, additional free-form BCAAs provide no incremental anabolic signal.
The Wolfe 2017 Review: The Definitive Summary
Robert Wolfe, one of the foremost researchers in protein and amino acid metabolism, published a comprehensive review in 2017 in the Journal of the International Society of Sports Nutrition that provides the most rigorous available assessment of BCAAs for muscle building. His conclusion is worth quoting directly:
“The claim that consumption of dietary BCAAs stimulates muscle protein synthesis or produces an anabolic response in human subjects is not supported by the empirical evidence.” He further argued that “dietary BCAAs alone cannot be used to create the amino acid conditions that may stimulate a maximal response of muscle protein synthesis; all the essential amino acids must be present for a complete anabolic response.”
A strong statement from a researcher with no financial interest in BCAA supplement sales — and it reflects the fundamental biochemical reality. Muscle protein synthesis requires all essential amino acids in roughly stoichiometric proportions to the proteins being synthesized. Provide only leucine, isoleucine, and valine without the other six essential amino acids, and the MPS signal from leucine can’t be fully executed, because the building materials — the other essential amino acids — are absent. The signal is on. The factory lacks parts.
Wolfe’s review also flagged a metabolic consequence rarely discussed: supplemental BCAAs in excess of muscle’s capacity to use them for protein synthesis require catabolism, and BCAA catabolism produces metabolic byproducts (particularly branched-chain keto acids) that require additional metabolic processing. In people with already-adequate protein intake, this is the actual fate of most of their BCAA supplement — metabolism and excretion rather than anabolism.
A 2017 study by Wolfe himself compared three groups: a BCAA supplement group (5.6g BCAAs post-workout), a whey protein group (25g post-workout), and a carbohydrate control. The BCAA group increased MPS by approximately 22% above baseline. The whey group increased MPS by approximately 60% above baseline. Whey protein — containing the same leucine as the BCAA supplement plus all other essential amino acids — produced nearly three times the MPS response. BCAAs stimulate MPS. Complete proteins stimulate it far more effectively.
When BCAAs Are Actually Useful: The Specific Cases
Calling BCAAs universally useless would be inaccurate — there are specific contexts where they provide genuine value. Understanding these contexts helps identify who should and shouldn’t spend money on them.
Fasted training: Training in a fully fasted state (no protein for 8+ hours before training) creates a context where muscle sits in net catabolic balance — protein breakdown exceeds synthesis. Consuming BCAAs before or during fasted training provides leucine to trigger MPS and BCAAs as substrates to limit muscle protein breakdown. A study by Jackman et al. (2010) found BCAAs significantly reduced muscle protein breakdown markers during prolonged cycling compared to placebo in fasted subjects. For people who train in the morning before breakfast and specifically want to preserve muscle while fasted, BCAAs have a rational application. Alternatively — and more effectively — consuming a small amount of whey protein before fasted training (20-25g) provides the BCAAs plus the full essential amino acid profile, a superior outcome. BCAAs in fasted training are a second-best option to complete protein in fasted training.
Vegans and those with low dietary protein: Plant-based proteins typically carry less leucine per gram of protein than animal proteins. Vegans eating protein primarily from rice, oats, legumes, and vegetables may have lower leucine intake relative to total protein. BCAA supplementation (specifically leucine) could help bridge that gap. The better solution, though, is leucine-enriched protein powder blends (pea protein combined with brown rice protein, or soy protein isolate) that provide adequate complete amino acid profiles. BCAAs alone remain the second-best option to a complete protein solution.
Ultra-endurance athletes: Events lasting 4+ hours involve significant protein catabolism as the body draws on amino acids for gluconeogenesis. BCAAs consumed during ultra-endurance events have evidence for both fuel provision and reduction of central fatigue — by competing with tryptophan for transport across the blood-brain barrier, reducing serotonin production and the associated fatigue sensation. For Ironman triathletes, ultramarathon runners, and 24-hour cyclists, intra-exercise BCAAs have a specific application that doesn’t exist for the gym-goer doing 60-minute resistance training sessions.
Caloric restriction and muscle preservation: During significant caloric restriction, the risk of muscle protein catabolism increases. Several studies have found BCAA supplementation during caloric restriction better preserves lean mass compared to low-protein control diets. The critical variable, though, is “low-protein control” — when total protein intake is adequate (1.8-2.2g/kg/day during a deficit), the additional BCAAs provide no measurable extra muscle-sparing benefit. Muscle preservation during caloric restriction comes from total protein adequacy, not BCAAs specifically.
The “Intra-Workout” BCAA Use Case
Intra-workout BCAAs — sipping a BCAA drink during training — is one of the most marketed uses and one of the most questionable from an evidence standpoint. The argument: providing BCAAs during the workout reduces muscle protein breakdown in real-time and keeps the anabolic machinery running during exercise. The evidence for this specific protocol in protein-sufficient athletes is poor.
During exercise, blood flow to the gut decreases — redirected to working muscle — and absorption of nutrients from the digestive tract slows significantly. The ability to effectively absorb and use amino acids during intense training is limited. The theoretical intra-workout benefits of BCAAs assume adequate absorption during exercise, which isn’t reliably achieved during high-intensity training.
A 2012 study by Bird et al. found that carbohydrate plus BCAA supplementation during resistance training increased various anabolic markers more than either alone or placebo. Frequently cited by BCAA proponents — but it used a fasted, low-protein population, and the improvements were against a low baseline. Subsequent studies with protein-sufficient populations haven’t replicated meaningful intra-workout BCAA benefits.
From a practical standpoint: eat adequate protein in the 2-3 hours before training, and blood BCAA levels are already elevated during the session. You’re supplementing an already-elevated baseline. The marginal impact is negligible. David was doing exactly this — eating a high-protein meal 90 minutes before training and then sipping BCAAs through his workout, supplementing a BCAA level that was already adequate for his muscle protein metabolism.
Opportunity Cost: What BCAAs Could Buy
Beyond the direct evidence question, there’s an opportunity cost argument rarely made but practically important: the money spent on BCAAs could buy supplements with substantially better evidence in the same budget.
At $40-60 per month, BCAAs compete for supplement dollars with: creatine monohydrate (arguably the most well-evidenced strength and muscle supplement, costing $15-20/month), omega-3 fish oil (EPA/DHA, with evidence for inflammation reduction, brain health, cardiovascular protection, costing $15-30/month), vitamin D3/K2 (deficiency is widespread, relevant for muscle function, hormone production, bone health, costing $10-15/month), or additional quality protein sources — food or protein powder, to ensure total protein adequacy, the thing BCAAs are trying to replicate at inferior effectiveness.
Not an abstract comparison. Choosing between BCAAs and creatine within a fixed supplement budget, the evidence clearly favors creatine. Choosing between BCAAs and omega-3s, omega-3s have broader evidence across more health outcomes. The question isn’t just “do BCAAs work?” It’s “do BCAAs work well enough to justify their cost relative to what else that money could do?”
For protein-sufficient athletes, the answer is clearly no.
The BCAA Decision Framework
A systematic approach to deciding whether BCAAs belong in your supplement protocol, based on your specific situation.
Step 1: Assess total daily protein intake
Consuming 1.6-2.2g of protein per kg of body weight daily from whole food and/or protein supplement sources? If yes, you’re protein-sufficient. For the protein-sufficient athlete, BCAAs are overwhelmingly unlikely to provide measurable benefit — the evidence consensus from Wolfe 2017 and multiple supporting studies confirms this. Save the money.
If no — total protein intake consistently below 1.4-1.6g/kg — the priority is increasing total protein, not adding BCAAs. Adding BCAAs while total protein is insufficient is like adding high-performance tires to a car that doesn’t have a working engine. Fix the engine first. Increase whole food protein or add a complete protein supplement.
Step 2: Assess training state
Consistently training in a fully fasted state (8+ hours since last protein-containing meal)? If yes, BCAAs have a specific application here — though 20-25g of complete protein before fasted training is a superior solution if practical. Training fasted and unable to eat solid food before training, BCAAs are a more convenient option than nothing, with the caveat that a leucine-enriched whey or EAA (essential amino acids) supplement would be more effective than BCAAs alone.
Step 3: Assess training duration and type
Regularly participating in training sessions or events lasting 3+ hours? If yes, BCAAs have an intra-exercise application for ultra-endurance contexts. If the longest sessions are 90-120 minutes, this application doesn’t apply.
The verdict for most people: Protein-sufficient, training fed, sessions under 2 hours — BCAAs provide no meaningful benefit. Redirect that budget to creatine, omega-3s, vitamin D, or additional whole food protein.
Essential Amino Acids vs BCAAs
A related product category — essential amino acid (EAA) supplements — has better evidence than BCAAs and is worth distinguishing. EAAs provide all nine essential amino acids (including the three BCAAs plus histidine, threonine, methionine, phenylalanine, tryptophan, and lysine), often in leucine-enriched formulations.
A 2016 study by Churchward-Venne et al. directly compared EAA supplementation, whey protein, and BCAAs on MPS stimulation. The EAA formula produced MPS stimulation comparable to whey protein — far superior to BCAAs alone — because it provided the full essential amino acid spectrum needed to execute the MPS signal leucine triggers. Confirms Wolfe’s argument: the complete essential amino acid set is required for maximal MPS.
EAAs represent a more rational choice than BCAAs in the specific contexts where amino acid supplementation provides value (fasted training, vegan populations seeking leucine augmentation). More expensive than BCAAs per gram, but more effective. The better comparison is EAAs versus whey protein — and for most people, whey protein, cheaper, providing all EAAs, more studied, remains the more rational choice.
A further consideration: the post-exercise anabolic window — the period after training when muscle is most primed for amino acid uptake — responds more completely to EAAs than to BCAAs. A 10-15g EAA supplement post-training provides the full suite of raw materials for muscle repair at a lower caloric cost than a full protein meal, making EAAs a legitimate tool for athletes wanting to trigger recovery without a large post-workout meal. BCAAs in the same context miss half the mechanism.
For the rare individual who, after honest self-assessment, concludes amino acid supplementation is warranted: upgrade from BCAAs to EAAs. The cost differential is minimal, the effectiveness differential substantial, and the evidence base for EAAs is stronger across the specific use cases where amino acid supplementation is defensible.
Common Questions About BCAAs Waste Money
- My coach says BCAAs are essential for muscle building. Should I listen to them? Many coaches and trainers recommend BCAAs based on how they were trained, what they personally use, or sponsorship relationships with supplement brands. Few are tracking the peer-reviewed literature on amino acid metabolism. The Wolfe 2017 review and the broader evidence base are clear: in protein-sufficient athletes, BCAAs don’t meaningfully add to muscle protein synthesis beyond what adequate dietary protein already provides. The coaching world has been significantly slower to update on this than the research world. Politely ask a coach for the specific research supporting BCAAs in this context, and show them the Wolfe review.
- If BCAAs aren’t useful, why does it feel like they help with training harder? Several possibilities: (1) BCAAs typically contain leucine, which may have modest direct CNS effects. (2) The BCAA drink may contain flavoring and carbohydrates that provide a sensory and fuel effect during training. (3) It may be a genuine placebo effect — knowing you’ve taken something that’s supposed to help improves performance through psychological mechanisms. (4) The hydration from sipping any drink during training improves performance independently. None of these require BCAAs specifically. If plain water or a flavored electrolyte drink produces the same perceived training quality, the BCAAs weren’t the active ingredient.
- Are there any benefits of BCAAs outside of muscle building? Leucine and other BCAAs have several non-muscle-building applications under study: hepatic encephalopathy (liver-related neurological condition) — BCAAs are used clinically as they can substitute for aromatic amino acids that the failing liver doesn’t metabolize correctly; some forms of PKU (phenylketonuria); and, as discussed, ultra-endurance fatigue reduction through tryptophan-serotonin competition. These are medical or specialized applications, not fitness supplements. For general population fitness purposes, these additional applications don’t change the cost-benefit assessment for typical athletes.
- What about flavored BCAA drinks as a replacement for sugary sports drinks? This is the most pragmatic BCAA use case and the one most defensible. If the alternative is a 250-calorie sports drink or soda during training, a low-calorie BCAA drink (typically 15-20 calories) is a better option for maintaining hydration and reducing caloric intake during training. In this framing, the amino acids aren’t the point — it’s a low-calorie flavored drink that happens to contain amino acids. A legitimate use case from a caloric standpoint, though an electrolyte drink or simply flavored water would serve the same purpose at lower cost.
- BCAAs reportedly reduce muscle soreness (DOMS). Is this true? A 2017 systematic review by Fouré and Bendahan found modest evidence that BCAA supplementation reduces delayed onset muscle soreness (DOMS) markers. The effect size was small in studies with adequate protein intake populations. A 2021 meta-analysis found significant reductions in muscle damage markers and DOMS with BCAA supplementation, but the magnitude was modest and the clinical significance questionable for most athletes. If DOMS management is a specific goal, the evidence suggests marginal benefit. But other recovery strategies — adequate sleep, dietary protein, progressive training that minimizes novel eccentric overload — address DOMS more fundamentally.
- Should BCAAs be taken during intermittent fasting? Training in the fasted state, BCAAs can help limit muscle protein breakdown during the fasted training period. However, consuming BCAAs technically breaks a true fast — the amino acids trigger insulin secretion and mTOR activation, ending the fasted biological state. Whether this matters depends on the reason for fasting — for the metabolic benefits of fasted training, BCAAs partially negate this; for caloric restriction where the point is simply not eating before training, BCAAs offer some muscle protection without significant calories. The nuance depends on the specific intermittent fasting protocol and goals.
- Are there any safety concerns with long-term BCAA use? At standard supplementation doses (5-20g per day), BCAAs are safe for healthy individuals. Long-term safety hasn’t been a concern in the literature. Some research has suggested that chronically elevated BCAA levels may be associated with insulin resistance — particularly relevant because high BCAA levels in the blood are a biomarker associated with metabolic dysfunction. This association is a marker of metabolic disease, though, not a causal relationship from supplementation. Supplementing BCAAs at typical doses in healthy individuals hasn’t been shown to cause insulin resistance. People with maple syrup urine disease (MSUD, a genetic disorder affecting BCAA metabolism) cannot process BCAAs and should avoid supplementation.
- What should be taken instead of BCAAs to support training? In order of evidence and cost-effectiveness: (1) Ensure adequate total protein intake from food — the most important intervention, no supplement required. (2) Creatine monohydrate — the most well-evidenced supplement for strength and muscle performance. (3) Omega-3 fatty acids — anti-inflammatory, supports brain and cardiovascular health, emerging evidence for muscle recovery. (4) Vitamin D3, guided by a baseline blood level — widespread deficiency, important for muscle function, immune function, and hormone production. (5) Whey protein if total protein from food is consistently inadequate. These four interventions, purchased with the budget previously spent on BCAAs, will provide better measurable outcomes than BCAAs provided for the majority of athletes.
BCAAs are the supplement category where the marketing industry convinced an entire generation of fitness enthusiasts to buy an incomplete version of something they already had. Eat adequate protein, and BCAAs come with it. They’re in the protein. No need to buy them again in powder form. The companies know this. They’re counting on you not knowing it.
David canceled his BCAA subscription. Redirected the $50/month to creatine ($15/month) and a high-quality fish oil ($20/month), pocketing the remaining $15. At six months, his strength had improved more than in any equivalent period in his training history — which he attributes entirely to the creatine, since he’d never taken it before. His training hadn’t changed. His protein intake hadn’t changed. The only variable was swapping BCAAs for something that actually worked at his protein intake level.
Four years buying water with amino acids he already had. Now he knew the difference.
The Leucine Threshold Model: How Muscle Protein Synthesis Actually Works
Leucine is the primary amino acid that activates mTORC1, the master regulator of muscle protein synthesis. When cellular leucine levels reach a threshold concentration — approximately 200-250 µmol/L in human plasma — mTORC1 activates a downstream signaling cascade that initiates ribosomal protein translation, the actual manufacturing of new muscle proteins. This leucine threshold is the anabolic trigger.
The critical detail: reaching the leucine threshold triggers the signal to start protein synthesis. But the actual synthesis requires all the essential amino acids (EAAs) in approximately the proportions needed to build the proteins being made. Cross the leucine threshold without adequate isoleucine, lysine, methionine, threonine, and tryptophan available, and the signal is on but the factory is running short on raw materials. Synthesis initiates briefly but can’t sustain the rate the signal is calling for. This is why Wolfe’s comparison showed whey (complete EAAs) producing triple the MPS response of BCAAs (only three EAAs) despite similar leucine content.
A meal providing 30-40g of high-quality protein (beef, chicken, fish, dairy, eggs, or a quality protein powder) delivers both the leucine threshold trigger and the full EAA complement for sustained synthesis. It also delivers additional nitrogen for the broader protein metabolism needs of recovery. BCAAs deliver only the trigger without the sustained synthesis support — a partial anabolic stimulus always outperformed by the complete protein alternative.
The practical implication for supplement design: to maximize muscle protein synthesis per dollar, maximize total high-quality dietary protein from whole foods and complete protein supplements. Leucine-rich complete proteins (whey, casein, egg white, soy isolate) provide both the trigger and the substrate. BCAAs provide only the trigger — a trigger already provided by dietary protein when intake is adequate.
The Supplement Hierarchy for Strength Athletes: Where BCAAs Fit
- Before spending on BCAAs, ensure these are in place: Creatine monohydrate — far better evidence for strength, power, muscle gain, and recovery. Omega-3s, as combined EPA/DHA — anti-inflammatory effects improve recovery quality. Vitamin D3 (maintain 50-70 ng/mL serum level) — relevant for muscle function, testosterone, and immune health
- Before spending on BCAAs, optimize this first: Total daily protein to 1.6-2.2g/kg/day from diverse quality sources. This single change will produce more measurable results than any stack of supplements on an inadequate protein foundation
- If you still want amino acids: EAAs rather than BCAAs, specifically for fasted training or as a calorie-low post-workout option when a full meal is inconvenient. 10-15g provides a meaningful anabolic stimulus without the caloric cost of a full protein serving
- BCAA appropriate uses: Ultra-endurance events (4+ hours), fasted training where EAAs aren’t available, and specific caloric restriction protocols where the third-best option (BCAAs) is what’s accessible. These are edge cases, not general strength training scenarios
Context is everything in supplement evaluation. BCAAs don’t exist in isolation — they compete for attention and budget within a supplement ecosystem that contains interventions with vastly different evidence bases. Understanding where BCAAs sit in the full hierarchy prevents the misallocation of supplement budget that affects most athletes who follow industry marketing rather than evidence.
The evidence hierarchy for strength and physique athletes is well-established by meta-analyses and systematic reviews. Tier 1 (strong evidence across multiple high-quality trials): creatine monohydrate, adequate total protein (not a supplement per se, but the most anabolic nutritional intervention available), caffeine for acute performance, and vitamin D3 for the substantial proportion of people who are deficient. Tier 2 (meaningful evidence, smaller effect sizes or more specific applications): omega-3 fatty acids (EPA/DHA for anti-inflammation and potential muscle protein synthesis augmentation), beta-alanine for high-intensity endurance (buffering carnosine), HMB for muscle preservation in severe catabolic states, and citrulline malate for performance. Tier 3 (weaker evidence, specific conditions only): EAAs for fasted training or protein-deficient states, casein protein for overnight recovery, tart cherry for anti-inflammatory recovery, magnesium for deficient individuals.
BCAAs for protein-sufficient athletes don’t appear in any tier of this hierarchy based on the evidence — they’re below Tier 3. For protein-deficient athletes or those in the specific contexts described (fasted training, ultra-endurance, vegan diets), BCAAs occupy a lower position within Tier 3 than EAAs, which are the superior alternative for the same applications.
The supplement industry generates substantial revenue by selling BCAAs to the large majority of its customers for whom BCAAs provide no marginal benefit beyond what their diet is already providing. The marketing works because the mechanism sounds compelling (leucine activates mTOR!), the product is not harmful, and it’s impossible for the individual user to notice what isn’t happening. You can’t see the MPS response you’re not getting. You can’t measure the creatine adaptation you’re foregoing. The invisibility of the counterfactual — what better supplements would have produced — makes the poor allocation invisible.
David’s story is not unusual. Four years and $2,000 in BCAAs, with results that would have occurred regardless, while creatine — which costs a quarter as much and has an evidence base ten times stronger — sat unused. The information gap is the problem. Now you have the information. Use it differently than he did.
The Protein Priority: Why Total Intake Beats Supplement Strategy Every Time
The most important takeaway from the BCAA evidence review — and from all amino acid supplement research — is that total dietary protein intake from complete sources is the foundation that determines whether any amino acid supplementation is relevant at all. Below the protein adequacy threshold, no supplement compensates effectively for the deficit. Above the threshold, most amino acid supplements add nothing measurable.
The current consensus on optimal protein intake for resistance-trained athletes and active adults is 1.6-2.2g/kg of body weight per day. For an 80kg man, this is 128-176g of protein daily. Most people who believe they eat “high protein” are consuming significantly less — commonly 80-120g/day. Tracking protein for a few days often reveals a substantial gap between perceived and actual intake, particularly for people who eat moderately portioned meals and don’t track systematically.
The protein sources that best support MPS combine leucine content (for the mTOR trigger), full EAA profile (for sustained synthesis), and digestibility. In descending order of leucine content and anabolic efficiency: whey protein concentrate/isolate (approximately 10-11g leucine per 100g protein), whole eggs (8.5g leucine/100g protein), beef and chicken (7-8g leucine/100g protein), fish (7-8g leucine/100g protein), dairy (cottage cheese, Greek yogurt — 8-9g leucine/100g protein), and soy protein isolate (7.6g leucine/100g protein). Plant proteins generally have lower leucine content per gram of total protein, which is one reason plant-based athletes may benefit from higher total protein targets (closer to 2.0-2.4g/kg) to achieve the same leucine threshold frequency.
For the practical athlete who has been spending on BCAAs: redirect the budget to ensuring protein quality and sufficiency first. A high-quality whey protein powder (30g serving provides 10+ grams of EAAs plus 2.5-3g of leucine) is categorically superior to a BCAA supplement for supporting MPS at the same or lower cost per serving. If your protein from food is already adequate, invest in creatine, omega-3s, and sleep quality before considering any amino acid supplement. The fundamentals, applied consistently, produce the results that sophisticated supplementation never will on a poor foundation.
The Future of Amino Acid Research: Where the Evidence Is Moving
The BCAA evidence picture may evolve as research tools improve and as research focuses on areas beyond the traditional athletic recovery applications that have dominated the literature. Several emerging areas are worth monitoring as the science develops over the next decade.
The gut microbiome-amino acid interaction is an area of genuine scientific interest. Specific amino acids — particularly glutamine, tryptophan, and to some extent BCAAs — affect the composition and metabolic activity of the gut microbiome in ways that may have health implications beyond muscle metabolism. Tryptophan, for example, is a precursor to both serotonin (90% of which is produced in the gut) and indole compounds produced by gut bacteria that modulate intestinal immune function and gut barrier integrity. Whether BCAA supplementation affects these gut-microbiome-mediated pathways in clinically meaningful ways is an open question that current research doesn’t definitively address.
Leucine’s role in mTOR activation has drawn interest in aging research, where the question is whether leucine or leucine-enriched protein intake can help preserve muscle mass in older adults facing sarcopenia. The anabolic resistance to protein in older muscle — where the leucine threshold to trigger MPS appears to increase with age — creates a legitimate theoretical argument for leucine-enriched protein (or EAA supplementation) in adults over 65 with reduced anabolic sensitivity. This is a different population and a different application than the athletic recovery context, and the evidence is more supportive here than in younger, protein-sufficient athletes. For older adults concerned about muscle loss, leucine-enriched protein or EAA supplementation may deserve a higher position in the evidence hierarchy than for their younger counterparts.
For now, the evidence base as it stands returns us to the same conclusion that applies across most supplement categories: extraordinary marketing claims require extraordinary evidence, and extraordinary evidence requires large, well-controlled human trials rather than cell culture and animal data extrapolation. The fitness industry’s relationship with BCAAs exemplifies the gap between those two standards. The informed athlete fills that gap with critical reading, not with a $50 powder that doesn’t do what the label implies.
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map